Publikationen von M. E. Keck

Keck, M. E.; Ohl, F.; Holsboer, F.; Müller, M. B.: Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neuroscience and Biobehavioral Reviews 29 (4-5 Sp. Iss.), S. 867 - 889 (2005)

Tichomirowa, M. A.; Keck, M. E.; Schneider, H. J.; Paez-Pereda, M.; Renner, U.; Holsboer, F.; Stalla, G. K.: Endocrine disturbances in depression. Journal of Endocrinological Investigation 28 (1), S. 89 - 99 (2005)

Erhardt, A.; Sillaber, I.; Welt, T.; Müller, M. B.; Singewald, N.; Keck, M. E.: Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology 29 (11), S. 2074 - 2080 (2004)

Erhardt, A.; Kern, N.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Unschuld, G.; Salyakina, D.; Pütz, B.; Holsboer, F.; Binder, E. B. et al.; Müller-Myhsok, B.; Keck, M. E.: Possible association of oxytocin and prolactin polymorphisms with panic and anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 66 (2004)

Keck, M. E.; Kern, N.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Salyakina, D.; Pütz, B. et al.; Holsboer, F.; Müller-Myhsok, B.; Binder, E.: Interactions of polymorphisms in corticotropin releasing hormone receptor 1 (CRHR1) and vasopressin receptor 1B (V1B) genes predispose for panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 64 - 65 (2004)

Kern, N.; Binder, E. B.; Pfennig, A.; Erhardt, A.; Ising, M.; Lucae, S.; Salyakina, D.; Pütz, B.; Holsboer, F.; Müller-Myhsok, B. et al.; Keck, M. E.: Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 67 (2004)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Kern, N.; Lucae, S.; Horstmann, S.; Salyakina, D.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B. et al.; Holsboer, F.; Keck, M. E.: Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 67 - 68 (2004)

Müller, M. B.; Uhr, M.; Holsboer, F.; Keck, M. E.: Hypothalamic-pituitary-adrenocortical system and mood disorders: Highlights from mutant mice. Neuroendocrinology 79 (1), S. 1 - 12 (2004)

Ohl, F.; Keck, M. E.: Behavioural screening in mutagenised mice-in search for novel animal models of psychiatric disorders. European Journal of Pharmacology 480 (1-3), S. 219 - 228 (2003)

Erhardt, A.; Welt, T.; Rödel, A.; Habersetzer, U.; Stecker, G.; Ohl, F.; Keck, M. E.: Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice - influence of CRH1-receptor antagonism. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Erhardt, A.; Welt, T.; Schmidt, W.; Sillaber, I.; Keck, M. E.: Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal. Pharmacopsychiatry 36 (5), S. 223 - 224 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders. Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Ohl, F.; Binder, E. B.; Rödel, A.; Weissenbacher, P.; Keck, M. E.: ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders. Pharmacopsychiatry 36 (5), S. 252 - 252 (2003)

Räder, H.; Grunze, H.; Ohl, F.; Keck, M. E.; Giegling, I.; Rujescu, D.: Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis. Pharmacopsychiatry 36 (5), S. 254 - 254 (2003)

Keck, M. E.: Neurobiologische Grundlagen des therapeutischen Einsatzes der repetitiven transkraniellen Magnetstimulation (rTMS) in der Psychiatrie. Nervenheilkunde 22, S. 253 - 260 (2003)

Keck, M. E.; Welt, T.; Erhardt, A.; Müller, M. B.; Sillaber, I.: Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation. Fokus auf Dopamin und Vasopressin. Nervenheilkunde 22 (7), S. 346 - 349 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 36 (1), S. 27 - 31 (2003)

Padberg, F.; Zinka, B.; Zwanzger, P.; Ella, R.; Rupprecht, R.; Keck, M. E.; Möller, H. J.: Präfrontale repetitive transkranielle Magnetstimulation in der Therapie depressiver Erkrankungen. Nervenheilkunde 22 (7), S. 331 - 340 (2003)

Czéh, B.; Welt, T.; Fischer, A. K.; Erhardt, A.; Schmitt, W.; Müller, M. B.; Toschi, N.; Fuchs, E.; Keck, M. E.: Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: Effects on stress hormone levels and adult hippocampal neurogenesis. Biological Psychiatry 52 (11), S. 1057 - 1065 (2002)